Pipeline

Cumberland Emerging Technologies

Cumberland Emerging Technologies (CET) provides access to a long term pipeline of innovative, biopharmaceutical product candidates. CET was established as a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University and the state of Tennessee to identify innovative product candidates and advance them from the laboratory to the marketplace. CET has formal collaboration agreements with leading academic research centers located in the mid-south region of the United States. Through these research centers CET evaluates a range of new emerging technologies and then teams with scientist to develop promising candidates. 

In addition to these development partnerships, CET manages a Life Sciences Center to support its activities and to help support the growth of the biomedical industry within Tennessee and the region. 

Dual Focus

Development Partnerships – CET works with researchers at universities and other organizations who seek a corporate partner to develop innovative research projects. CET identifies promising therapeutics, diagnostics and other technologies with high commercial potential and provides support to expedite development and improve the probability of success. CET’s role includes technology evaluation, product development, grant program management and commercialization support.

CET Life Sciences Center – CET has also formed the CET Life Sciences Center, a business incubator facility that provides laboratory and office space, equipment, and infrastructure to early-stage biomedical companies. Located in the heart of downtown Nashville and just minutes away from renowned research centers including Vanderbilt University, this vibrant Life Sciences Center houses CET’s activities and also creates a collaborative setting to support other life science initiatives.

visit www.cet-fund.com for more information
click here to view Cumberland Objectivity in Research Policy